Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Advisors

Pzena Mid Cap Value Fund Investor Class (PZVMX)

Ticker PZVMX · Since 2014-03-31 · · Holdings as of May 31, 2026

Expense ratio
1.25%$125/yr per $10k
5-yr return
+8.2%annualized
1-yr return
−1.2%as of Dec 2025
Net assets
$102.3Mall share classes
Holdings
40

Bottom line

Is PZVMX a good fund? The bottom line

PZVMX is the Investor Class share class of Pzena Mid Cap Value Fund, a managed mid-cap mutual fund from Advisors.

It charges 1.25% — about $125 a year on every $10,000 invested, more expensive than 81% of mid-cap funds we track.

It returned −1.2% over one year, +8.2% a year over five years, +8.5% a year over ten (as of Dec 31, 2025, per its prospectus).

With $102 million in net assets and 40 holdings, its largest position is Humana Inc (6.7%) and the top 10 make up 40.1% of the portfolio.

What to watch

  • Expensive for its category (1.25%)
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What PZVMX invests in

The Pzena Mid Cap Value Fund (the Mid Cap Fund or Fund) seeks to achieve long-term capital appreciation.

Under normal market conditions, the Mid Cap Fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in stocks of mid-cap value companies. The Fund defines a mid-cap company as an issuer whose market capitalization at the time of initial purchase, is in the range of those found in the Russell Midcap Index (mid cap companies). As of May 31, 2026, the market capitalization of companies in the Russell Midcap Index ranged from $81.45 million to $251.01 billion. The Fund defines value companies as those that are in the three cheapest quintiles of valuation of the investment universe based on estimated future earnings. In choosing individual securities, the Adviser screens a dynamic universe of 1,000 U.S. companies, ranked 201-1200 by market capitalization, and uses fundamental research and proprietary modeling to rank these companies from cheapest to most…

From the fund's prospectus (filed Jun 26, 2026).

PZVMX performance

Average annual total returns
1 yr5 yr10 yr
PZVMX−1.2%+8.2%+8.5%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full PZVMX performance history →

What PZVMX costs

On a $10,000 investment, PZVMX's 1.25% expense ratio costs about $125 a year. The prospectus estimates $1,677 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full PZVMX fee table →

PZVMX top 10 holdings

#Holding% of fund
1Humana Inc HUM6.74%
2Advance Auto Parts Inc AAP5.45%
3Baxter International Inc BAX4.40%
4Skyworks Solutions Inc SWKS3.84%
5Sensata Technologies Holding P ST3.73%
6Robert Half Inc RHI3.36%
7Magna International Inc MGA3.26%
8Knight-Swift Transportation Ho KNX3.25%
9Dollar General Corp DG3.08%
10Oshkosh Corp OSK3.02%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 40.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to PZVMX

More funds like PZVMX →

PZVMX FAQ

What is the expense ratio of PZVMX?
PZVMX's expense ratio is 1.25%, which works out to about $125 a year for every $10,000 invested. The prospectus estimates total costs of $1,677 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PZVMX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.25%); 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does PZVMX hold?
PZVMX's largest holdings are Humana Inc (6.7%), Advance Auto Parts Inc (5.4%), Baxter International Inc (4.4%), Skyworks Solutions Inc (3.8%), Sensata Technologies Holding P (3.7%). It holds 40 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is PZVMX's 5-year return?
PZVMX returned +8.2% a year over the five years ending Dec 31, 2025, and +8.5% a year over ten years. Past performance does not guarantee future results.
Who manages PZVMX?
PZVMX is offered by Advisors through Advisors Series Trust.